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Title: Divergent sensory phenotypes in non-specific arm pain: 23 
comparison with cervical radiculopathy 24 
ABSTRACT  25 
Objective: The primary research question under review was whether distinct sensory 26 
phenotypes were identifiable in individuals with non-specific arm pain (NSAP) and if they 27 
differed from people with cervical radiculopathy. A secondary question considered whether 28 
the frequency of features of neuropathic pain, kinesiophobia, high pain ratings, hyperalgesia 29 
and allodynia differed according to sub-groups of sensory phenotypes.   30 
 31 
Design: A cross sectional study 32 
 33 
Setting: Higher education institution 34 
Participants: Forty office people with NSAP, 17 with cervical radiculopathy, and 40 age- 35 
gender-matched healthy controls. 36 
 37 
Interventions: Nil 38 
 39 
Main Outcome Measures: Participants were assessed using quantitative sensory testing (QST) 40 
comprising thermal and vibration detection thresholds, and thermal and pressure pain 41 
thresholds; clinical examination and relevant questionnaires. Sensory phenotypes were 42 
identified for each individual in the patient groups using z-score transformation of the QST 43 
data.   44 
 45 
Results: Individuals with NSAP and cervical radiculopathy present with a spectrum of 46 
sensory abnormalities; a dominant sensory phenotype was not identifiable in individuals with 47 
NSAP. No distinct pattern between clinical features and questionnaire results across sensory 48 
phenotypes was identified in either group. 49 
 50 
Conclusion: When considering sensory phenotypes, neither individuals with NSAP nor 51 
cervical radiculopathy should be considered homogenous. Therefore, people with either 52 
condition may warrant different intervention approaches according to their individual sensory 53 
3 
 
phenotype. Issues relating to the clinical identification of sensory hypersensitivity and the 54 
validity of QST are highlighted. 55 
 56 
Abbreviations: QST: quantitative sensory testing; NSAP: Non-specific arm pain; 57 
LANSS: Leeds assessment for neuropathic symptoms and signs 58 
 59 
Keywords: Sensory threshold; pain threshold; non-specific arm pain (repetitive strain 60 




INTRODUCTION  63 
 64 
Work related upper limb disorders are a significant public health problem with a prevalence 65 
of 29% (Eurostat),
1
 50% of which are described as non specific.
2
 Non-specific arm pain 66 
(NSAP) commonly affects computer users and is frequently associated with poor prognoses.
3
 67 
The absence of consistent information regarding the pathology and pathophysiology 68 
underlying NSAP has obvious implications for clinical decision making. Given growing 69 
computerisation of the global workforce as well as the intensification of work, improving our 70 
understanding of work related non-specific conditions is imperative for improving 71 
intervention selection and outcomes. 72 
 73 
Quantitative sensory testing (QST) is a non-invasive means of assessing sensory and pain 74 
perception, which potentially provides insights into underlying pathophysiological 75 
mechanisms of a condition,
4
 and has seen growing use in the investigation of patient 76 
populations such as complex regional pain syndrome, whiplash and neuropathic pain.
5-10
 In 77 




 which may suggest the presence of a minor neuropathy
11 12
 and/or altered central 79 
processing,
13
 possibly secondary to pain.
14
 Furthermore, we recently reported the presence of 80 
sensory hypersensitivity to pressure, cold and heat as characteristic of NSAP, while 81 
hypoaesthesia to vibration explained a small percentage of the variance (11%).
15
 In addition, 82 
in comparison to people with cervical radiculopathy and healthy controls, people with NSAP 83 
had normal thermal detection thresholds, whereas sensory hypoaesthesia, to both thermal and 84 




The German Research Network on Neuropathic Pain has suggested that detailed analyses of 87 
sensory profiles may yield information regarding the underlying sensory phenotype in 88 
individuals and within patient populations and that this may help to direct clinical decision 89 
making.
16
 They presented data from a large group of people with various neuropathy and 90 
neuropathic pain conditions with key sensory phenotypes identified i.e. sensory loss, sensory 91 
hypersensitivity, both sensory hypersensitivity + sensory loss and no abnormality.
6
 Each of 92 
the phenotypes was represented both within each patient population and across the different 93 
conditions studied.
6
 A further study by Gierthmühlen et al.
5
 identified the presence of 94 
different sensory phenotypes in people with complex regional pain syndrome, with some 95 
people exhibiting increased sensitivity while others demonstrated decreased sensitivity to 96 
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thermal and mechanical stimuli; thus, comparison of mean values may not thoroughly 97 
represent sensory findings in patient groups. Therefore, while results from between group 98 
comparisons identified the presence of sensory hypersensitivity as well as hypoaesthesia to 99 
vibration in NSAP, the presence of various sensory phenotypes or indeed a dominant sensory 100 
phenotype is not yet known in this group.  101 
 102 
The use of QST in clinical practice has limitations in that equipment is not widely available 103 
and as such, understanding the relationship between QST findings and clinical features of 104 
pain and clinical signs of sensory loss or sensory hypersensitivity is important. Previous 105 
reports suggest that pain and disability ratings are poorly correlated with QST findings;
17
 106 
however, data on the relationship between clinical features of pain in study populations sub-107 
grouped according to sensory phenotype is lacking and warrants further investigation. 108 
 109 
The primary research question under review in this study was whether distinct phenotypes are 110 
identifiable in NSAP and if they differ to cervical radiculopathy, a known neuropathic 111 
disorder. A secondary question considered whether the frequency of features of neuropathic 112 
pain, kinesiophobia, high pain ratings, hyperalgesia and allodynia differed according to sub-113 
groups of sensory phenotypes. We hypothesised that individuals with NSAP would present 114 
with a spectrum of sensory phenotypes within the group and that group sensory phenotypes 115 
would differ between NSAP and cervical radiculopathy. We also hypothesized that people 116 
with sensory hypersensitivity on QST would present with higher pain ratings, clinical 117 





A cross-sectional observational study investigating sensory profiles in participants with 123 
NSAP, cervical radiculopathy and healthy controls was undertaken. Volunteers were 124 
screened for inclusion criteria for each particular group, the criteria for which have been 125 
previously reported.
15
 Subsequently, participants underwent a physical examination and QST 126 
and were asked to complete a series of questionnaires for self-reported pain features and 127 
kinesiophobia. All aspects of group allocation and data collection were performed by one 128 
investigator (NM). The order of QST testing was randomized. The study was approved by the 129 
Human Research Ethics Committee for Life Sciences in University College Dublin and the 130 
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involved hospitals. All participants were unpaid volunteers and all provided written informed 131 
consent before inclusion.  132 
 133 
Participants 134 
In relation to NSAP, volunteers with arm pain, aged between 18-65 years old that were 135 
recruited from metropolitan hospitals, medical and physiotherapy practices and via a multi-136 
media campaign were screened for inclusion in this study (through a medical history and 137 
physical examination). Participants were assigned to the NSAP group if they had pain in the 138 
arm in the absence of a specific diagnosis,
18
 were office workers who had significant upper 139 
limb pain as defined by a numerical pain rating of ≥3/10,
19 20
 for longer than 3 months, who 140 
spent more than 40% of their working week using desktop equipment,
12
 and who had been 141 
employed using desk-top equipment for at least two years.
21
 142 
Participants with possible cervical radiculopathy were recruited from metropolitan hospitals 143 
as well as medical and physiotherapy practices. They were assigned to the cervical 144 
radiculopathy group if they had all of the following: radicular pain in the upper limb 145 
(≥3/10),
19 20
 a positive upper limb neurodynamic test, a positive Spurling’s test, MRI 146 
confirmation of nerve compression,
22-24
 as well as at least one concordant clinical sign of 147 
conduction loss
25
 (i.e. one of diminished/absent reflexes, myotomal weakness or sensory loss 148 
in a dermatomal pattern).  149 
Control participants were included  if they did not have a history of significant neck, scapular 150 
or shoulder pain over the previous 12 months and did not use desktop equipment for more 151 
than 40% of their working week.
12
 As participants from the cervical radiculopathy group 152 
were older than the non-specific arm pain group, control participants were age- and gender-153 
matched to each group.  154 
Volunteers were excluded from the study if they had any of the following: generalized 155 
neurological disorders, generalized musculoskeletal/inflammatory disorders, a history of low 156 
back pain and/or low back related leg pain over the previous six months, a history of 157 
migraine over the previous six months, previous trauma to the upper quadrant, diabetes, 158 
endocrine disorders, epilepsy or if they had been diagnosed with any mental health / 159 




Measurements  164 
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Sensory assessment 165 
A previously published QST protocol was undertaken
26
 measuring the following parameters: 166 
cold, warm and vibration detection thresholds; cold, heat and pressure pain thresholds. All 167 
measures were recorded on three sites on each upper limb. Thermal and vibration tests were 168 
performed using a NeuroSensory Analyser (TSA 2001 II Medoc, Israel). For thermal testing, 169 
a Peltier thermode (16 x 16mm) was attached directly over sites in the hand innervated by 170 
C6, C7 and C8. A Vibrameter (VSA 3000 II 2001 Medoc, Israel) was used to measure 171 
vibration thresholds with readings taken over sites of the hand innervated by C6, C7 and C8. 172 
Pressure pain thresholds were determined using a hand held pressure algometer with a probe 173 
size of 1cm² (Somedic AB, Farsta, Sweden) and an application rate of 40 kPa/s over the 174 
median nerve (cubital fossa), ulnar nerve (between olecranon and medial epicondyle of the 175 
humerus) and radial nerve (mid-lower third of the humerus). Triplicate recordings were taken 176 
at each site for all QST parameters and the mean values used for analyses. In order to assess 177 
the presence of widespread sensitivity, thermal testing and pressure pain thresholds were 178 
recorded at a site remote from the upper quadrant, in this case, unilaterally over Tibialis 179 
anterior muscle. All aspects of QST have been found to have acceptable reliability.
27-29
  180 
 181 
Hyperalgesia to pin prick was assessed by recording pain responses to a pin-prick stimulus 182 
applied in the affected area compared to an unaffected area i.e. the contralateral limb where 183 
possible, otherwise the nearest pain-free area was used. The presence of hyperalgesia was 184 
determined if the response in the affected area was more painful than in the unaffected area.
30
 185 
Allodynia was assessed by moving a brush over the affected area and comparing the response 186 
to that in an unaffected area. The stimulus was applied with a single light stroke of at least 187 





Self-reported measures of pain and fear avoidance 191 
All participants in the patient groups completed the following questionnaires: the Leeds 192 
Assessment for Neuropathic Symptoms and Signs (LANSS) questionnaire with a score of 193 
≥12 (out of 24) indicating the possible presence of neuropathic pain;
31
 the Tampa Scale of 194 
Kinesiophobia 
32
 with a score of ≥37 (out of 68) considered to indicate the presence of 195 
significant fear-avoidant pain beliefs,
33
 and all provided an average numerical pain rating 196 




Data Analysis 199 
Data were analysed using SPSS software, version 19.0 (SPSS, USA).  200 
Preliminary data management 201 
QST data were log-transformed before statistical analyses in order to achieve normal 202 
distribution of the data,
4
 which subsequent analysis revealed was successful. Friedman’s tests 203 
were used to assess the effect of test site between upper limb sites (C6, C7 & C8 dermatomes 204 
or median, ulnar & radial nerves) for QST parameters. As no significant differences were 205 
identified for QST parameters between these sites, data were averaged and the resultant value 206 
used for subsequent analyses.  207 
Z-transformation 208 
To compare sensory phenotypes of individuals with NSAP or cervical radiculopathy with 209 
age-matched healthy controls, QST data were z-transformed to generate z-scores, which 210 
allows scores from individuals with a condition to be directly compared to ‘normals’ in order 211 
to identify any abnormality in that individual, as has been previously advocated for 212 
assessment of individual sensory profiles.
6 16
 QST data were z-transformed using the mean 213 
(SD) of their respective control group as reference data i.e. control participants were divided 214 
into two groups; one group of 40 participants matched, according to age and gender, to the 40 215 
participants with NSAP and a further group of 14 participants matched to the cervical 216 
radiculopathy group. The formula used for z-transformation was: Z-score = (X single 217 
participant – Mean controls) / SD controls.
4
 For clarity of data presentation, the algebraic sign 218 
of the resulting z-score was adjusted appropriately so that it reflected patients’ sensitivity for 219 
each parameter i.e. values above zero indicated increased sensitivity to the tested stimuli; 220 
values below zero indicated reduced sensitivity to the tested stimuli.  221 
 222 
Sensory phenotypes for each participant were assessed by generating sensory phenotype 223 
graphs using resultant z-scores. Z-scores of > 1.96 was considered indicative of increased 224 
sensitivity to the tested stimuli compared with controls (hyperalgesia/allodynia), while z-225 
scores of < -1.96 was considered indicative of sensory loss.
6
 Each individual was classified 226 
according to their sensory phenotype into one of six possible phenotypes: (1) sensory losssmall 227 
i.e. small fibre sensory loss as determined in this study by the presence of cold and/or warm 228 
hypoaesthesia; (2) sensory losslarge i.e. large fibre sensory loss as determined by the presence 229 
of vibration hypoaesthesia; (3) sensory lossmixed i.e. a combination of small and large fibre 230 
sensory loss; (4) sensory hypersensitivity as determined by the presence of hyperalgesia in 231 
response to cold pain, and/or heat pain and/or pressure pain thresholds; (5) a combination of 232 
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sensory hypersensitivity + sensory loss, and (6) no abnormality.
6
 When sensory 233 
hypersensitivity was recorded, data were inspected to see if hypersensitivity was localised to 234 
upper limb sites or if it was widespread i.e. included sensory hypersensitivity at the Tibialis 235 
Anterior site. 236 
The frequencies of different sensory phenotypes in each patient group were recorded and 237 
between-group comparisons of sensory phenotypes were conducted using percentage risk 238 
difference with 95% confidence intervals.  239 
 240 
Sample size: 241 
The sample size was calculated based on mean and standard error vibration threshold data 242 
from a study by Greening et al., (2003). A sample of size of 40 participants with NSAP, 40 243 
participants with cervical radiculopathy and 40 matched control subjects was required to 244 
detect a medium effect size (0.5) with 0.8 power and 0.05 two tailed significance level. 245 
 246 
RESULTS 247 
Characteristics of NSAP and cervical radiculopathy groups 248 
The baseline characteristics of participants are presented in Table 1. The groups were similar 249 
with regards to pain duration; however, the cervical radiculopathy group were older 250 
(p<0.001) and more disabled (p=0.002) than the NSAP group. The cervical radiculopathy 251 
sample was smaller than anticipated (n=17), primarily due to the strict inclusion criteria. The 252 
control group for the NSAP group comprised of 40 age- and gender- matched healthy people, 253 
while the control group for the cervical radiculopathy group comprised of 14 age- and 254 
gender- matched healthy people.  255 
Individual sensory phenotypes are presented in Table 2. Overall, both groups presented with 256 
divergent sensory phenotypes; 45% of the NSAP group and 35% of the cervical 257 
radiculopathy group presented with the phenotypes ‘sensory hypersensitivity’ and ‘sensory 258 
hypersensitivity + sensory loss’. A further 30% of both groups had evidence of ‘sensory 259 
loss’. No sensory abnormality was evident in 25% (n=10) of the NSAP group and 35% (n=6) 260 
of the cervical radiculopathy group.  261 
Results from risk difference analyses revealed no significant differences between the groups 262 
with respect to the frequency of sensory phenotype. Equal numbers of participants presented 263 
with localised and widespread sensory hypersensitivity in both groups. 264 
 265 
Clinical features and questionnaire results across sensory phenotypes   266 
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The frequency of LANSS scores ≥12, Tampa scale of kinesiophobia scores ≥37, pain 267 
>/<5/10, hyperalgesia and allodynia across each sensory phenotype in both patient groups is 268 
depicted in Table 3. No distinct pattern was evident with respect to the representation of 269 
questionnaire results, high pain levels or clinical measures of hypersensitivity across sensory 270 
phenotypes in either patient group. Those with widespread sensory hypersensitivity did not 271 




Sensory phenotypes in NSAP and cervical radiculopathy 276 
The results of this study provide evidence of bi-directional sensory abnormalities in 277 
individuals with NSAP with evidence that a distinct sensory phenotype is not evident in these 278 
individuals. While bi-directional sensory abnormalities were also evident in individuals with 279 
cervical radiculopathy, it was notable that 35% of the cervical radiculopathy group presented 280 
with no sensory abnormality using QST. The presence of bi-directional sensory abnormalities 281 
in both groups in this study is consistent with data from a similar cohort of people with neck 282 
and arm pain,
34
 as well as other cohorts with neuropathies and complex regional pain 283 
syndrome.
5 6
 This further supports the argument for assessment of sensory phenotypes in 284 
patient populations on the basis that heterogeneity with respect to sensory phenotypes exists 285 
within patient cohorts; hence, people with the same condition could warrant different 286 
approaches to assessment and treatment.
6 35
  287 
 288 
The identification of different sensory phenotypes within NSAP is an important finding. 289 
Whilst we previously reported group data indicating that sensory hypersensitivity was a key 290 
characteristic in this group,
15
 the current findings indicate that just over 50% of the NSAP 291 
group did not have signs of sensory hypersensitivity and presented with either sensory 292 
hypoaesthesia or no sensory abnormality. The identification of the absence or presence of 293 
sensory hypersensitivity is important as the presence of sensory hypersensitivity has been 294 
shown to be a predictor of poor prognosis and poor treatment response in other 295 
musculoskeletal populations, 
7 38 39
 and thus, may be an important consideration in NSAP and 296 
cervical radiculopathy. Further, the presence of sensory hypersensitivity is important 297 
clinically in considering appropriate interventions in order to prevent acute exacerbations of 298 
symptoms. For example, people with sensory hypersensitivity have previously been shown to 299 
have less effective descending pain modulation in response to exercise;
40
 therefore, selected 300 
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exercise dosages would need careful consideration in a patient with a dominance of sensory 301 
hypersensitivity. However, for those identified with sensory hypoaesthesia or no sensory 302 
abnormality, it is possible that their prognosis is more favourable, although prospective 303 
studies are required to elucidate this further. 304 
 305 
Almost half of the NSAP group and 35% of the cervical radiculopathy group in this study 306 
presented with sensory hypersensitivity, which likely reflects mechanisms of peripheral and 307 
central sensitisation. In addition, 27% of the NSAP group presented ‘sensory loss + sensory 308 
hypersensitivity’. This may reflect the interplay between the mechanisms of hypoaesthesia 309 
and hypersensitivity. The presence of pain has been shown to cause an increase in detection 310 
thresholds;
14
 in contrast, the presence of neuronal insult, as has been suggested in NSAP
36
 311 
may lead to sensitisation of peripheral and central pathways.
37
 Both scenarios could explain 312 
the presentation of sensory hypersensitivity in addition to sensory loss.  313 
.  314 
 315 
Clinical features and sensory phenotypes 316 
How to identify sensory hypersensitivity in clinical practice is an important consideration. 317 
Currently, there are neither established guidelines nor validated measures to do this and 318 
whether QST could fill this void is hampered by the limited availability of equipment in 319 
clinical practice, as well as the large variability in normative data and lack of established cut-320 
off values. Recent guidelines for the assessment of neuropathic pain recommend that if QST 321 
is used in clinical practice, it should only form part of an overall clinical assessment.
42
 This 322 
raises the question whether self-reports of pain intensity and features of bedside examination 323 
are valid means of assessing sensory hypersensitivity. Previous meta-analysis indicated that 324 
QST measures of sensory hypersensitivity and self-reported pain and disability were poorly 325 
correlated; 
41
 however, it was highlighted in that study that many of the study participants 326 
included in the analysis may not have been sensitised, in which case a strong relationship 327 
between QST and self-reports of pain and disability would not be expected.
41
 In the current 328 
study, we aimed to investigate whether particular clinical features would be more frequent 329 
among sub-groups of sensory phenotypes. Specifically, we hypothesized that higher levels of 330 
pain, higher scores on neuropathic pain and kinesiophobia questionnaires and clinical features 331 
of hypersensitivity (pin-prick hyperalgesia and allodynia) would be more evident in those 332 
with the phenotype ‘sensory hypersensitivity’; however, we did not find a distinct pattern in 333 
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either the NSAP or cervical radiculopathy groups, even when comparing those with a sensory 334 
abnormality to those without a sensory abnormality.  335 
Relatively few people with NSAP in this study (28%) presented with kinesiophobia with no 336 
demonstrable pattern noted across different phenotypes. The cervical radiculopathy group 337 
presented with kinesiophobia more frequently (59% of participants), with 24% of those with 338 
kinesiophobia demonstrating sensory hypersensitivity as their dominant sensory phenotype. 339 
Both groups had over 60% of participants presenting pain rating ≥5, but no discernible 340 
pattern was evident regarding which sensory phenotypes presented with higher pain ratings. 341 
Indeed, nine of the 13 people with no sensory abnormality in the NSAP group had a pain 342 
rating of ≥5. In considering these findings, it is important to note that the small sample size 343 
and particularly the small numbers in each subgroup, mean these data should be considered 344 
preliminary and as such, further studies on larger sample sizes are warranted.  345 
 346 
Nonetheless, the challenge of how to assess the presence of sensory hypersensitivity in 347 
clinical practice without using QST remains. One reason for the poor relationship between 348 
QST and clinical measures may be that the clinical measures tested to date against QST are 349 
not measuring the same construct. Two clinical measures that may be useful are pin-prick 350 
hyperalgesia and brush stroke allodynia
43
 but these measures were rarely positive in this 351 
study, despite the frequent presence of sensory hypersensitivity to other measures e.g. heat 352 
and cold. Recently, stronger correlations were identified between pain ratings on application 353 
of ice versus cold pain thresholds;
44
 therefore, this may be a better clinical measure of cold 354 
sensitivity. A final consideration is that, QST, which quantifies responses to experimentally 355 
induced pain may evoke different central nervous system responses than spontaneous pain, 356 
normally experienced by patients, as has been demonstrated by brain imaging studies.
45
 357 
Therefore, the development of better clinical tools for the assessment of sensory 358 
hypersensitivity is needed. The recommendation that assessment of descending pain 359 
modulation and pain magnitude rating for a suprathreshold stimulus might facilitate a better 360 
understanding of a sensitized nociceptive system rather than threshold measures may also 361 
hold validity.
46
  362 
 363 
Study Limitations 364 
Due to the relatively small sample size of this study, particularly for cervical radiculopathy, 365 
and the small numbers in each sensory phenotype group, these results should be considered 366 






The results of this study demonstrate divergent sensory phenotypes in NSAP as well as in 371 
cervical radiculopathy with implications for clinical decision making. NSAP and cervical 372 
radiculopathy should not be considered homogenous groups and individuals may warrant 373 
different intervention approaches according to their sensory phenotype. Researchers should 374 
also consider this when stratifying people for intervention studies. Identifying the presence of 375 
sensory hypersensitivity is difficult in clinical practice and while some studies have reported 376 
criteria for classifying pain;
47-49
 validated tools are still lacking with further research needed 377 
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